Literature DB >> 28363823

Sustained tocilizumab-induced hypofibrinogenemia and thrombocytopenia. Comment on: "Tocilizumab-induced hypofibrinogenemia: A report of 7 cases" by Martis et al., Joint Bone Spine 2016, doi: 10.1016/j.jbspin.2016.04.008.

Gianfranco Vitiello1, Carolina Orsi Battaglini2, Anna Radice2, Giulia Carli2, Serena Micheli3, Daniele Cammelli4.   

Abstract

Entities:  

Keywords:  Biologics; Hypofibrinogenemia; Interleukin-6; Large-vessel vasculitis; Tocilizumab

Mesh：

Substances：

Year:  2017        PMID： 28363823     DOI： 10.1016/j.jbspin.2017.02.012

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  1 in total

Review 1.  Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review.

Authors:  Döndü Üsküdar Cansu; Ezgi Demirtaş; Neslihan Andiç; Hava Üsküdar Teke; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2019-03-14       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.